Steven V. Pacia, MD, has been appointed Director of the Division of Neurology at Lenox Hill Hospital. The appointment, effective October 15, 2004, was announced by Robert A. Phillips, MD, PhD, Chairman, Department of Medicine.
Dr. Pacia comes to Lenox Hill Hospital from New York University School of Medicine where he was Associate Professor of Neurology and Director of the Clinical Neurophysiology Residency program. "He is a highly regarded neurologist with a special interest in the treatment of epilepsy as well as seizures in patients with brain tumors," said Dr. Phillips. "Dr. Pacia brings to Lenox Hill Hospital proven leadership skills, clinical expertise and a vision for expanding neurosciences at the Hospital to include centers of excellence in subspecialty neurological care, including epilepsy, stroke, neuro-oncology, and clinical neurophysiology."
Dr. Pacia earned his medical degree in 1987 from the Medical College of Wisconsin and completed his residency in Neurology at the Yale School of Medicine in 1991. That same year, he was awarded the prestigious Gilbert Glaser Fellowship in Epilepsy and in 1992, was awarded the highly competitive Victor Horsley Research Fellowship from the Epilepsy Foundation of America. Together with Yale faculty member, Dr. John Ebersole, Dr. Pacia's research lead to a new noninvasive method of seizure localization for patients with temporal lobe epilepsy.
In 1993, Dr. Pacia joined the faculty of the Neurology Department at NYU as director of the clinical neurophysiology laboratory. He will bring his experience to Lenox Hill Hospital to establish a comprehensive epilepsy treatment center that will include fellowship training for Neurologists in epilepsy treatment and clinical neurophysiology.
Dr. Pacia has published numerous peer reviewed articles on the presurgical evaluation of patients with epilepsy and is a principal investigator of the first NIH- funded multicenter epilepsy surgery study to analyze surgical and neuropsychological outcomes. He is also the co-developr of a new microelectrode. This microsensor, smaller than a human hair, is able to detect neurotransmitters and other vital neurochemicals in the brain. The technology holds promise for the diagnosis and treatment of Parkinson's Disease, brain tumors, cerebrovascular disease, epilepsy and many other neurological disorders.
Members of the press seeking information about Lenox Hill Hospital should call the Public Relations Department at (212) 434-2400.